Related Experiment Video
Updated: Jul 18, 2026

Antibiotic Dereplication Using the Antibiotic Resistance Platform
Published on: October 17, 2019
Bacterial efflux pump inhibitors from natural sources
Michael Stavri1, Laura J V Piddock, Simon Gibbons
1Centre for Pharmacognosy and Phytotherapy, The School of Pharmacy, University of London 29-39 Brunswick Square, London, UK.
Multidrug resistance (MDR) in bacteria is a growing threat. This review explores plant-derived efflux pump inhibitors (EPIs) as a strategy to combat MDR and restore antibiotic effectiveness.
Area of Science:
- Microbiology
- Pharmacology
- Natural Products Chemistry
Background:
- Multidrug resistance (MDR) in bacteria, driven by efflux pumps, compromises antibiotic efficacy.
- Efflux pumps actively expel diverse compounds, including critical antibiotics, leading to therapeutic failure.
- Rapid evolution of resistance necessitates novel antibacterial and resistance-modifying agents.
Purpose of the Study:
- To review natural product-derived bacterial efflux pump inhibitors (EPIs).
- To highlight the potential of EPIs in combating MDR bacterial infections.
- To assess EPIs as leads for future clinical development.
Main Methods:
- Literature review of scientific publications on bacterial efflux pumps and EPIs.
- Focus on EPIs derived from natural sources, particularly plants.
- Analysis of resistance-modifying activities and clinical potential.
Main Results:
- Efflux pumps are key contributors to bacterial multidrug resistance.
- Numerous chemical classes of EPIs have been identified from natural sources.
- EPIs show promise in restoring sensitivity to existing antibiotics and preventing resistance.
Conclusions:
- Bacterial efflux pump inhibitors (EPIs) are crucial for addressing the MDR crisis.
- Plant-derived EPIs represent a promising avenue for novel therapeutic strategies.
- Further research into EPIs is warranted for clinical development to combat MDR strains.
More Related Videos
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Inhibitors of Bacterial DNA Synthesis
Inhibitors of Gram-positive Cell Wall Synthesis
Development of Antibiotic Resistance
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Inhibitors of Bacterial Protein Synthesis

